2006
DOI: 10.1021/jm060133g
|View full text |Cite
|
Sign up to set email alerts
|

Novel Selective Inhibitors of Neutral Endopeptidase for the Treatment of Female Sexual Arousal Disorder. Synthesis and Activity of Functionalized Glutaramides

Abstract: Female sexual arousal disorder (FSAD) is a highly prevalent sexual disorder affecting up to 40% of women. We describe herein our efforts to identify a selective neutral endopeptidase (NEP) inhibitor as a potential treatment for FSAD. The rationale for this approach, together with a description of the medicinal chemistry strategy, lead compounds, and SAR investigations are detailed. In particular, the strategy of starting with the clinically precedented selective NEP inhibitor, Candoxatrilat, and targeting low … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 35 publications
0
29
0
Order By: Relevance
“…[130] One of the compounds (65) that contains the 1,2,3-triazole exhibited appreciable potency (82 nm) against NEP.…”
Section: Antifungal and Antibacterialsmentioning
confidence: 99%
“…[130] One of the compounds (65) that contains the 1,2,3-triazole exhibited appreciable potency (82 nm) against NEP.…”
Section: Antifungal and Antibacterialsmentioning
confidence: 99%
“…This fixed combination is in currently in Phase 3 clinical trials for chronic heart failure. Discovery of carboxylate containing NEP inhibitors (16) and (17) have also been reported and are being developed as medicines for treatment of female sexual arousal disorder [37,38]. Their discovery was based on candoxatrilat as a start point.…”
Section: Recent Advances In Medicinal Chemistry Of Nep Inhibitorsmentioning
confidence: 99%
“…NEP in endometrial stromal cells has been proposed as a helpful tool in diagnosis of endometriosis (Groisman and Meir 2003). The involvement of the enzyme in the hydrolysis of the vasoactive intestinal peptide (VIP) was the basis for a recent study that resulted in the development of very selective inhibitors for NEP, which can be used in the treatment of female sexual arousal disorder (Pryde et al 2006). It was suggested that, by selective NEP inhibition, VIP levels could increase thereby enhance VIP-induced increase in vaginal blood flow (Pryde et al 2006).…”
Section: Neprilysin Carboxydipeptidase Specificity Studies and Improvmentioning
confidence: 99%
“…The involvement of the enzyme in the hydrolysis of the vasoactive intestinal peptide (VIP) was the basis for a recent study that resulted in the development of very selective inhibitors for NEP, which can be used in the treatment of female sexual arousal disorder (Pryde et al 2006). It was suggested that, by selective NEP inhibition, VIP levels could increase thereby enhance VIP-induced increase in vaginal blood flow (Pryde et al 2006). NEP is widely distributed and is present in the endothelial surface of several tissues where other important related peptidases are also located, such as angiotensin I-converting enzyme (ACE).…”
Section: Neprilysin Carboxydipeptidase Specificity Studies and Improvmentioning
confidence: 99%